In Vitro & In Vivo Diagnostic Substances
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 12.68M | $74.0M | 38.88% | +753.0K | 2026-06-30 |
| AWM Investment Company, Inc. | 2.84M | $16.0M | 8.70% | +30.4K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 735.8K | $4.0M | 2.26% | +198.7K | 2026-06-30 |
| PURA VIDA INVESTMENTS, LLC | 484.8K | $2.0M | 1.49% | -462.3K | 2026-06-30 |
| Family Office Research LLC | 368.8K | $2.0M | 1.13% | +241.6K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 256.9K | $1.0M | 0.79% | -5.2K | 2026-06-30 |
| FNY Investment Advisers, LLC | 182.6K | $1.0M | 0.56% | -64.9K | 2026-06-30 |
| JANE STREET GROUP, LLC | 157.7K | -- | 0.48% | +115.2K | 2026-06-30 |
| BlackRock, Inc. | 150.5K | -- | 0.46% | +15.2K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 124.6K | -- | 0.38% | -8.0K | 2026-06-30 |
